CIM Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-2,300
| Closed | -$222K | – | 277 |
|
2021
Q4 | $222K | Buy |
+2,300
| New | +$222K | 0.07% | 268 |
|
2021
Q3 | – | Sell |
-3,454
| Closed | -$283K | – | 315 |
|
2021
Q2 | $283K | Buy |
+3,454
| New | +$283K | 0.09% | 222 |
|
2021
Q1 | – | Sell |
-3,921
| Closed | -$243K | – | 312 |
|
2020
Q4 | $243K | Hold |
3,921
| – | – | 0.08% | 237 |
|
2020
Q3 | $233K | Buy |
3,921
+58
| +2% | +$3.45K | 0.09% | 214 |
|
2020
Q2 | $270K | Buy |
+3,863
| New | +$270K | 0.11% | 181 |
|
2020
Q1 | – | Sell |
-3,206
| Closed | -$209K | – | 220 |
|
2019
Q4 | $209K | Sell |
3,206
-2,509
| -44% | -$164K | 0.08% | 203 |
|
2019
Q3 | $355K | Hold |
5,715
| – | – | 0.13% | 192 |
|
2019
Q2 | $407K | Sell |
5,715
-112
| -2% | -$7.98K | 0.15% | 162 |
|
2019
Q1 | $457K | Buy |
5,827
+2,417
| +71% | +$190K | 0.18% | 143 |
|
2018
Q4 | $289K | Buy |
+3,410
| New | +$289K | 0.13% | 217 |
|
2017
Q4 | – | Sell |
-4,166
| Closed | -$354K | – | 331 |
|
2017
Q3 | $354K | Sell |
4,166
-4,174
| -50% | -$355K | 0.13% | 224 |
|
2017
Q2 | $632K | Sell |
8,340
-262
| -3% | -$19.9K | 0.22% | 111 |
|
2017
Q1 | $568K | Hold |
8,602
| – | – | 0.2% | 137 |
|
2016
Q4 | $545K | Hold |
8,602
| – | – | 0.2% | 143 |
|
2016
Q3 | $548K | Buy |
8,602
+337
| +4% | +$21.5K | 0.21% | 125 |
|
2016
Q2 | $615K | Buy |
+8,265
| New | +$615K | 0.25% | 111 |
|
2016
Q1 | – | Sell |
-4,894
| Closed | -$331K | – | 279 |
|
2015
Q4 | $331K | Hold |
4,894
| – | – | 0.15% | 160 |
|
2015
Q3 | $261K | Buy |
4,894
+585
| +14% | +$31.2K | 0.13% | 187 |
|
2015
Q2 | $271K | Sell |
4,309
-4,314
| -50% | -$271K | 0.12% | 182 |
|
2015
Q1 | $415K | Hold |
8,623
| – | – | 0.18% | 141 |
|
2014
Q4 | $286K | Buy |
8,623
+1,193
| +16% | +$39.6K | 0.13% | 167 |
|
2014
Q3 | $218K | Buy |
+7,430
| New | +$218K | 0.11% | 166 |
|